Posted inBrain Content Type: Service Drugs (Pharmaceuticals) Food and Drug Administration Health Insurance and Managed Care Medicare
What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDA
Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow cognitive decline.